LONDON — The U.S., Canada and U.K. are among some of the high-income countries actively blocking a patent-waiver proposal designed to boost the global production of Covid-19 vaccines.
Members of the World Trade Organization will meet virtually in Geneva, Switzerland on Thursday to hold informal talks on whether to temporarily waive intellectual property and patent rights on Covid vaccines and treatments.
The landmark proposal, which was jointly submitted by India and South Africa in October, has been backed by more than 100 mostly developing countries.
It aims to facilitate the manufacture of treatments locally and boost the global vaccination campaign.
The urgency and importance of waiving certain intellectual property rights amid the pandemic have been underscored by the WHO, health experts, civil society groups, trade unions, former world leaders, international medical charities, Nobel laureates and human rights organizations.
Dr, Maria Guevara
World Health Organization, World Trade Organization, Sans Frontieres, WHO
Covid, New Delhi, India, U.S, Canada, Geneva, Switzerland, South Africa, EU, Japan, Norway, Australia, Brazil